Final answer:
Tracers used in nuclear medicine with short half-lives decay rapidly, reducing patient radiation exposure. They do not pose a higher risk of radiation exposure and require special handling only for a brief duration.
Step-by-step explanation:
Short half-lives of tracers used in nuclear medicine imply that they decay rapidly, reducing patient radiation exposure.
Because these tracers have a short half-life, they do not remain radioactive for an extended period. This characteristic ensures that the tracers do not pose a higher risk of radiation exposure to the patient.
Tracers with short half-lives require special handling only for a brief duration, as they rapidly decay and become non-radioactive.